Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Ventyx Biosciences Inc

VTYX
Current price
2.17 USD -0.01 USD (-0.46%)
Last closed 2.17 USD
ISIN US92332V1070
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 157 592 096 USD
Yield for 12 month -93.66 %
1Y
3Y
5Y
10Y
15Y
VTYX
21.11.2021 - 28.11.2021

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California. Address: 12790 El Camino Real, San Diego, CA, United States, 92130

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-941 000 USD

Last Year

-470 000 USD

Current Quarter

-316 000 USD

Last Quarter

-408 000 USD

Key Figures VTYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -185 548 992 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -35.29 %
PEG Ratio
Return On Equity TTM -56.29 %
Wall Street Target Price 10 USD
Revenue TTM
Book Value 3.97 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.78 USD
Diluted Eps TTM -2.78 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics VTYX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History VTYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation VTYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -22.9297
Price Book MRQ 0.5612

Financials VTYX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators VTYX

For 52 weeks

1.79 USD 38.2 USD
50 Day MA 2.32 USD
Shares Short Prior Month 9 006 148
200 Day MA 3.58 USD
Short Ratio 8.73
Shares Short 9 335 315
Short Percent 15.47 %

Dynamics of changes in the value of assets

D

DO4C

3.66 EUR DOREL INDS INC. A 0 (0%)
Detailed analytics
D

DO4B

4.14 EUR DOREL INDS INC. B 0 (0%)
Detailed analytics
8

88M

21.10 EUR HEXAOM S.A. EO -18 0 (0%)
Detailed analytics
C

CRZK

5.92 EUR CR Capital AG +0.07 (+1.02%)
Detailed analytics
V

VNJA

5.00 USD Vanjia Corp 0 (0%)
Detailed analytics